Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.43M Buy
25,473
+1,189
+5% +$114K 0.02% 522
2026
Q1
$2.52M Buy
24,284
+153
+0.6% +$17.3K 0.02% 507
2025
Q4
$2.43M Hold
24,131
0.02% 501
2025
Q3
$3M Hold
24,131
0.03% 461
2025
Q2
$2.9M Buy
24,131
+1,017
+4% +$136K 0.03% 458
2025
Q1
$3.4M Hold
23,114
0.04% 412
2024
Q4
$3.75M Sell
23,114
-3,071
-12% -$502K 0.04% 401
2024
Q3
$4.27M Sell
26,185
-256
-1% -$37.9K 0.04% 390
2024
Q2
$3.61M Buy
26,441
+120
+0.5% +$16.7K 0.04% 412
2024
Q1
$4.03M Hold
26,321
0.04% 376
2023
Q4
$3.75M Sell
26,321
-642
-2% -$85.6K 0.05% 367
2023
Q3
$3.53M Buy
26,963
+1,011
+4% +$154K 0.05% 372
2023
Q2
$4.13M Buy
25,952
+3,952
+18% +$637K 0.05% 343
2023
Q1
$3.48M Buy
22,000
+838
+4% +$126K 0.05% 353
2022
Q4
$2.97M Buy
21,162
+2,164
+11% +$307K 0.05% 369
2022
Q3
$2.44M Hold
18,998
0.04% 384
2022
Q2
$2.68M Buy
18,998
+54
+0.3% +$7.71K 0.05% 378
2022
Q1
$2.63M Buy
18,944
+2,905
+18% +$445K 0.04% 413
2021
Q4
$2.8M Sell
16,039
-229
-1% -$38.2K 0.05% 361
2021
Q3
$2.69M Hold
16,268
0.06% 349
2021
Q2
$2.93M Buy
16,268
+2,188
+16% +$399K 0.06% 318
2021
Q1
$2.72M Buy
14,080
+2,114
+18% +$407K 0.07% 282
2020
Q4
$2.42M Buy
11,966
+1,556
+15% +$322K 0.08% 260
2020
Q3
$2.19M Buy
10,410
+1,174
+13% +$261K 0.09% 209
2020
Q2
$2.03M Sell
9,236
-5,204
-36% -$1.04M 0.1% 190
2020
Q1
$2.52M Sell
14,440
-503
-3% -$83.1K 0.11% 172
2019
Q4
$2.29M Buy
14,943
+1,831
+14% +$274K 0.08% 256
2019
Q3
$1.99M Buy
13,112
+3,877
+42% +$613K 0.07% 284
2019
Q2
$1.41M Buy
9,235
+1,219
+15% +$186K 0.08% 272
2019
Q1
$1.29M Buy
8,016
+742
+10% +$115K 0.08% 251
2018
Q4
$1.12M Buy
7,274
+610
+9% +$95K 0.09% 230
2018
Q3
$1M Buy
6,664
+869
+15% +$123K 0.08% 274
2018
Q2
$784K Buy
5,795
+1,636
+39% +$202K 0.07% 288
2018
Q1
$554K Buy
4,159
+432
+12% +$58K 0.08% 277
2017
Q4
$554K Hold
3,727
0.09% 266
2017
Q3
$492K Hold
3,727
0.08% 274
2017
Q2
$497K Buy
3,727
+977
+36% +$132K 0.09% 264
2017
Q1
$371K Buy
+2,750
New +$356K 0.09% 258

Other funds holding CLX

IFM Investors's CLX Position: Q2 2026 in Review

IFM Investors increased its Clorox (CLX) stake by 4.9% in Q2 2026, buying an estimated $114K and bringing the position to 25,473 shares worth $2.43M. The position accounts for 0.02% of the portfolio, ranked #522.

IFM Investors first reported a position in CLX in Q1 2017 and has held it in 38 quarters since. The position peaked at $4.27M in Q3 2024. 286 funds tracked by Wall St. Rank hold CLX as of Q2 2026.

  • IFM Investors held 25,473 shares of Clorox worth $2.43M as of Q2 2026.
  • IFM Investors bought 1,189 Clorox shares in Q2 2026, an estimated $114K.
  • Clorox made up 0.02% of IFM Investors's portfolio in Q2 2026, its #522 holding.
  • IFM Investors first reported a position in Clorox in Q1 2017 and has held it in 38 quarters since.
  • IFM Investors's Clorox position peaked at $4.27M in Q3 2024.
  • 286 funds tracked by Wall St. Rank held Clorox as of Q2 2026.

Based on IFM Investors's 13F filing for Q2 2026, filed 21 Jul 2026.